These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience. Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244 [TBL] [Abstract][Full Text] [Related]
24. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx. Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867 [TBL] [Abstract][Full Text] [Related]
25. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity. Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368 [TBL] [Abstract][Full Text] [Related]
26. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma. Doweck I; Robbins KT; Samant S; Vieira F World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553 [TBL] [Abstract][Full Text] [Related]
27. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Barker JL; Glisson BS; Garden AS; El-Naggar AK; Morrison WH; Ang KK; Chao KS; Clayman G; Rosenthal DI Cancer; 2003 Dec; 98(11):2322-8. PubMed ID: 14635065 [TBL] [Abstract][Full Text] [Related]
28. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728 [TBL] [Abstract][Full Text] [Related]
29. [Cervical lymphatic metastases from occult primary tumor. A nation-wide 20-year study from the Danish society of head and neck oncology]. Grau C; Johansen LV; Jakobsen J; Geertsen PF; Andersen EV; Jensen BB Ugeskr Laeger; 2001 Mar; 163(10):1432-6. PubMed ID: 11257752 [TBL] [Abstract][Full Text] [Related]
30. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Schuller DE; Wilson HE; Smith RE; Batley F; James AD Cancer; 1983 Jan; 51(1):15-9. PubMed ID: 6185194 [TBL] [Abstract][Full Text] [Related]
31. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679 [TBL] [Abstract][Full Text] [Related]
33. Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma. Lam P; Yuen AP; Ho CM; Ho WK; Wei WI Eur J Surg Oncol; 2001 Dec; 27(8):750-3. PubMed ID: 11735172 [TBL] [Abstract][Full Text] [Related]
34. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. Robbins KT; Kumar P; Harris J; McCulloch T; Cmelak A; Sofferman R; Levine P; Weisman R; Wilson W; Weymuller E; Fu K J Clin Oncol; 2005 Mar; 23(7):1447-54. PubMed ID: 15735120 [TBL] [Abstract][Full Text] [Related]
35. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061 [TBL] [Abstract][Full Text] [Related]
36. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma. Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745 [TBL] [Abstract][Full Text] [Related]
37. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity]. Watanabe N; Kaneko T; Fujitani S; Umeyama M; Nomura Y; Zusho H; Yamada Y; Nanba G; Asahina N; Sugio Y; Okamoto Y; Daida T; Tokumaru T Gan To Kagaku Ryoho; 1999 Jan; 26(1):101-6. PubMed ID: 9987505 [TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma of the oral cavity and oropharynx. Lindberg RD Ear Nose Throat J; 1977 Mar; 56(3):102-9. PubMed ID: 852442 [No Abstract] [Full Text] [Related]
39. [Head and neck cancer: choice of treatment in relation to clinical and pathological findings]. Ono I Gan To Kagaku Ryoho; 1986 Jan; 13(1):18-23. PubMed ID: 3942398 [TBL] [Abstract][Full Text] [Related]
40. Current management of carcinoma of the oropharynx. Gluckman JL; Zitsch RP Oncology (Williston Park); 1990 Apr; 4(4):23-30; discussion 32, 34, 43. PubMed ID: 2143928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]